To statin or to non-statin in coronary disease-considering absolute risk is the answer.
Christopher M
CM
Rembold
D054058:Acute Coronary Syndrome / Q000473:pathology; D050197:Atherosclerosis / Q000188:drug therapy / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000473:pathology*; D004032:Diet; D005227:Fatty Acids / Q000378:metabolism; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009525:Niacin / Q000378:metabolism; D012044:Regression Analysis; D012107:Research Design; D012306:Risk
D008078:Cholesterol, LDL; D005227:Fatty Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009525:Niacin; D015248:Gemfibrozil